Literature DB >> 24439517

Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Robert K McNamara1, Therese Rider2, Ronald Jandacek2, Patrick Tso2.   

Abstract

This study investigated the fatty acid composition of the postmortem superior temporal gyrus (STG), a cortical region implicated in emotional processing, from normal controls (n=15) and patients with bipolar disorder (BD, n=15), major depressive disorder (MDD, n=15), and schizophrenia (SZ, n=15). For comparative purposes, STG fatty acid composition was determined in a separate cohort of multiple sclerosis patients (MS, n=15) and normal controls (n=15). Compared with controls, patients with BD, but not MDD or SZ, exhibited abnormal elevations in the saturated fatty acids (SFA) palmitic acid (16:0), stearic acid (18:0), the polyunsaturated fatty acids (PUFA) linoleic acid (18:2n-6), arachidonic acid (20:4n-6), and docosahexaenoic acid (22:6n-3), and reductions in the monounsaturated fatty acid (MUFA) oleic acid (18:1n-9). The total MUFA/SFA and 18:1/18:0 ratios were lower in the STG of BD patients and were inversely correlated with total PUFA composition. MS patients exhibited a pattern of fatty acid abnormalities similar to that observed in BD patients including elevated PUFA and a lower 18:1/18:0 ratio. Collectively, these data demonstrate that BD patients exhibit a pattern of fatty acid abnormalities in the STG that is not observed in MDD and SZ patients and closely resembles MS patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Lithium; Major depressive disorder; Multiple sclerosis; Schizophrenia; Valproic acid

Mesh:

Substances:

Year:  2014        PMID: 24439517      PMCID: PMC3949121          DOI: 10.1016/j.psychres.2013.12.022

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  84 in total

1.  Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia.

Authors:  Mikael Landén; Pia Davidsson; Carl-Gerhard Gottfries; Jan-Eric Månsson; Kaj Blennow
Journal:  Schizophr Res       Date:  2002-05-01       Impact factor: 4.939

Review 2.  Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

Authors:  Katherine M Appleton; Peter J Rogers; Andrew R Ness
Journal:  Am J Clin Nutr       Date:  2010-02-03       Impact factor: 7.045

3.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

4.  Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia.

Authors:  Meena Arvindakshan; Madhav Ghate; Prabhakar K Ranjekar; Denise R Evans; Sahebarao P Mahadik
Journal:  Schizophr Res       Date:  2003-08-01       Impact factor: 4.939

5.  Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects.

Authors:  Robert K McNamara; Jessica Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  J Psychiatr Res       Date:  2008-11-04       Impact factor: 4.791

6.  Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder.

Authors:  Clare L Beasley; Mrinalini Honavar; Ian P Everall; David Cotter
Journal:  Schizophr Res       Date:  2009-12       Impact factor: 4.939

7.  A high prevalence of organ-specific autoimmunity in patients with bipolar disorder.

Authors:  Roos C Padmos; Lynn Bekris; Esther M Knijff; Henning Tiemeier; Ralph W Kupka; Dan Cohen; Willem A Nolen; Ake Lernmark; Hemmo A Drexhage
Journal:  Biol Psychiatry       Date:  2004-10-01       Impact factor: 13.382

8.  Red blood cell fatty acids in multiple sclerosis.

Authors:  X Navarro; R Segura
Journal:  Acta Neurol Scand       Date:  1989-01       Impact factor: 3.209

9.  Mood disorder and multiple sclerosis.

Authors:  R T Joffe; G P Lippert; T A Gray; G Sawa; Z Horvath
Journal:  Arch Neurol       Date:  1987-04

10.  The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system.

Authors:  Guan-Yeu Diau; Andrea T Hsieh; Eszter A Sarkadi-Nagy; Vasuki Wijendran; Peter W Nathanielsz; J Thomas Brenna
Journal:  BMC Med       Date:  2005-06-23       Impact factor: 8.775

View more
  10 in total

Review 1.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

Review 2.  Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.

Authors:  R J T Mocking; J Assies; H G Ruhé; A H Schene
Journal:  J Inherit Metab Dis       Date:  2018-03-09       Impact factor: 4.982

3.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

4.  Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Authors:  Emma Em Knowles; Peter J Meikle; Kevin Huynh; Harald Hh Göring; Rene L Olvera; Samuel R Mathias; Ravi Duggirala; Laura Almasy; John Blangero; Joanne E Curran; David C Glahn
Journal:  Bipolar Disord       Date:  2017-02-23       Impact factor: 6.744

5.  Dietary Long-Chain n-3 Polyunsaturated Fatty Acid Supplementation Alters Electrophysiological Properties in the Nucleus Accumbens and Emotional Behavior in Naïve and Chronically Stressed Mice.

Authors:  Mathieu Di Miceli; Maud Martinat; Moïra Rossitto; Agnès Aubert; Shoug Alashmali; Clémentine Bosch-Bouju; Xavier Fioramonti; Corinne Joffre; Richard P Bazinet; Sophie Layé
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

6.  Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls.

Authors:  Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

7.  Bipolar disorder moderates associations between linoleic acid and markers of inflammation.

Authors:  Ya-Wen Chang; Shervin Assari; Alan R Prossin; Laura Stertz; Melvin G McInnis; Simon J Evans
Journal:  J Psychiatr Res       Date:  2016-10-27       Impact factor: 4.791

8.  Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Wen-Jang Chu; Wade A Weber; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello
Journal:  Nutr Neurosci       Date:  2016-03-02       Impact factor: 4.994

9.  Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: A proton magnetic resonance spectroscopy study.

Authors:  Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Serdar Süleyman Can; Görkem Karakaş Uğurlu; Semra Ulusoy Kaymak; Ali Çayköylü; Oktay Algın; Mary L Phillips; Constance M Moore; Dost Öngür
Journal:  J Affect Disord       Date:  2018-04-04       Impact factor: 4.839

10.  Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder.

Authors:  Lan-Ying Liu; Hong-Jian Zhang; Li-Yuan Luo; Jin-Bao Pu; Wei-Qing Liang; Chun-Qin Zhu; Ya-Ping Li; Pei-Rong Wang; Yuan-Yuan Zhang; Chun-Yu Yang; Zhang-Jin Zhang
Journal:  Chin Med       Date:  2018-10-25       Impact factor: 5.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.